cancer

articles with this tag

GTG Validates Cancer Tests As it Looks to Global Expansion

GTG Validates Cancer Tests As it Looks to Global Expansion

What if there was a cost effective way for patients to assess their cancer risk and seek treatment? There is. Genetic Technologies (ASX:GTG; NASDAQ:GENE).

READ ARTICLE

ASX Med-Tech’s Genetic Cancer Screening Enters China, Eyes Future Asian Growth

ASX Med-Tech’s Genetic Cancer Screening Enters China, Eyes Future Asian Growth

Genetic Technologies (ASX:GTG) is a provider of world-leading genetic risk assessment test products.

READ ARTICLE

Could a Loxo Oncology Style Trial, Bring Loxo Style Results for PTX?

Could a Loxo Oncology Style Trial, Bring Loxo Style Results for PTX?

Clinical stage oncology company, Prescient Therapeutics (ASX:PTX) is in a fortunate position. It has two clinical candidates, four trials, and multiple possible pathways to market for its targeted therapies that address specific mutations that drive cancer and contribute to resistance.

READ ARTICLE

ASX Biotech Eyes International Distribution of Overlooked Cancer Drug

ASX Biotech Eyes International Distribution of Overlooked Cancer Drug

Today’s biotech junior is in the business of repurposing late-stage drug assets that have been overlooked by big pharma.

READ ARTICLE

Thanks for subscribing!

X